Health related quality of life in colorectal cancer patients: state of the art by Marventano, Stefano et al.
RESEARCH ARTICLE Open Access
Health related quality of life in colorectal cancer
patients: state of the art
Stefano Marventano1, Maria Joao Forjaz2, Giuseppe Grosso3, Antonio Mistretta1, Gabriele Giorgianni1,
Alessio Platania1, Santi Gangi4, Francesco Basile4, Antonio Biondi4*
From 26th National Congress of the Italian Society of Geriatric Surgery
Naples, Italy. 19-22 June 2013
Abstract
Background: Colorectal cancer (CRC) is the third most commonly diagnosed cancer in males and the second in
females with a progressive increase in prevalence in industrialized countries. The loss of health due to the cancer
and/or the consequence of the treatment may result in psychophysical, functional and social impairment; all of
these affect health-related quality of life (QoL).
Description: The most frequently CRC-specific QoL questionnaires is the FACT-C. QoL is not only important for the
well-being of cancer patient but it also influences survival and response to therapy. Many studies investigated
various determinants involved in the assessment of QoL in CRC, suggesting that symptoms, surgical procedures
and the number of comorbidity significantly affected QoL.
Conclusion: Despite that CRC patients have a relatively good QoL compared with the general population, a wide
range of intervention could be undertaken to improve their QoL. The finding of this review may be useful for
cancer clinicians in taking therapy and surveillance-related decisions. However, future research should be directed
to large-scale prospective studies using well validated QoL instruments to facilitate comparison of results.
Background
Colorectal cancer (CRC) is the third most commonly diag-
nosed cancer in males and the second in females, with
over 1.2 million new cancer cases [1]. In the past two dec-
ades incidence rates for CRC have remained largely
unchanged, instead mortality rates have fallen due to
improvements in early detection and cancer treatment
[2,3]. Survival at 5 years is 56% in Europe and 66% in the
United States of America [4]. Moreover, Baade et al. con-
cluded that survival expectations increase the longer they
survive, reaching 93.2 % at 5 years after diagnosis [5]. This
leads to a rising prevalence of patient living with CRC
with an estimated worldwide prevalence of more than 3
million persons within 5 years of diagnosis in 2008 [6].
The rise of patients living with the consequence of CRC
and its treatment has increased greatly the interest of their
impact on health-related quality of life (QoL) [7]. The loss
of health due to the cancer and/or the consequence of the
treatment may result in psychophysical or functional
impairment or disruption of social and family interactions,
all of these affect QoL [8]. Several studies assess prospec-
tively the impact of CRC in the patient’s QoL, both in
short-term [9,10] and long-term periods [11].
In the present article, we review the studies in color-
ectal cancer that have incorporated previously validated
instruments.
Quality of life: definition and assessment
QoL is a multimensional, dynamic, subjective and cen-
tered on patient construct, comprising physical, func-
tional, emotional, and social/family well-being [12].
Therefore, QoL is an important outcome for evaluating
the full impact of the disease on the individuals, their
family and their community [13].
Quality of life, being a subjective, patient-rated con-
cept, is difficult to quantify. To assess QoL the use of
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patient-reported questionnaires has become a standard
practice. However the lack of a “gold standard” instru-
ment is reflected in the wide range of available instru-
ments, generic or disease-specific. The most used
questionnaires are presented in table 1. Short Form
36 (SF-36) [14], its short version (SF-12) [15] and the
EQ-5D [16] are the some of the most frequent generic
questionnaire used to assess QoL. The use of generic
QoL instruments allows comparison with the general
population, or with people with no cancer. Instead,
some cancer-specific questionnaires are the Functional
Assessment of Cancer Therapy-General (FACT-G) [17]
and the European Organization for the Research and
Treatment of Cancer QLQ-C30 (EORTC QLQ-C30)
[18]. The FACT-C [17] is the most used CRC specific
questionnaire, although the EORTC also has a CRC-spe-
cific module, the QLQ-CR29 [19]. The FACT-C, used
together with the FACT-G, has been extensively vali-
dated in English [20], Spanish [21] Korean [22], French
[23] and Chinese patients [24]. It is formed by 37 items,
grouped in five dimensions with a time frame of seven
days. The first four dimensions are subscales of the
FACT-G [20] (physical, social/family, emotional and
functional well-being) and the last is an additional one
focused on CRC. All the items are based on a five-point
Likert scale except for the one investigating the presence
of stoma (yes/no). This questionnaire was principally
designed for self-administration, but it can also be admi-
nistered by interviewers [25]. Both total and single
dimensions scores could be calculated to assess QoL in
CRC patient.
Determinant of quality of life
QoL in colorectal cancer patients is associated with a
several number of factors. To simplify the discussion,
we divided these factors into five broad categories:
socio-demographic characteristics; health-related factors;
cancer-related and surgical procedures factors; lifestyle
factors; and other factors.
Socio-demographic characteristics
Gender has not been reported as significant determinant
in patients’ QoL [26]. However, this is not true for spe-
cific problems like sexual functioning in man [27] or
physical problems and pains in woman [28].
Results on age and CRC QoL are controversial. Fors-
berg et al. reported that age did not play a significant
role in patients’ QoL [29]. Nevertheless, in some studies
QoL increase with age [30,31], whereas others reported
a lower QoL with increasing age [32,33]. This contro-
versy is present for both physical and psychological
aspect of QoL [34].
Education level is not a determinant for QoL, because
its role is subordinated to income [35]. With regards to
income, there is evidence that low income correlates
with worse physical, social and emotional well-being
dimensions of QoL[11,31,35]. Also, home ownership
was an independent predictor of QoL score [36].
The presence of a wide social network is positively
related to patient’s QoL [32]. Patients living alone
reported a lower perceived well-being than those who
live with family [29], but marital status was not associated
with a higher QoL [11].
Health-related factors
Patient with CRC reported significantly more comorbid-
ity conditions and poorer physical and mental QoL com-
pared with patients without cancer and a worse effect
was found in patient with two or more comorbidities or
those who had recent diagnosis [37]. Some specific dis-
eases, such as heart disease [38], anxiety/depression [36]
or urinary disorder [30] had a significant role on overall
QoL. In particular, the higher prevalence of depression,
compared to the general population of similar age [11]
could be partially explained by the worries of a recur-
rence or of a second cancer, even after 5 or more years
after diagnosis of cancer [39].
Concerning the association between body mass index
and QoL, healthy-weight and overweight cancer survi-
vors reported better scores in physical functioning, gen-
eral health and vitality than obese cancer survivors [40].
Cancer-related and surgical procedures factors
The stage and site of colorectal cancer at diagnosis are
important in determining QoL, as they determine symp-
toms, treatment modalities and therapy duration [41,42].
Patient with stage I experienced a progressive positive
trend in QoL; on the contrary patient with stage IV experi-
enced a negative one. Instead, an initial QoL decrease,
followed by better QoL scores, was experienced by those
with stage II and stage III [43]. A possible explanation
Table 1 List of QoL tools frequently used in oncology
Name of instruments Type








EORTC QLQ-CR29 [19] CRC specific
mCOH-QOL and abridged version for non-stoma
patients [85]
CRC specific
FACT-C [17] CRC specific
EORTC= European Organization for the Research and Treatment of Cancer;
FACT= Functional Assessment of Cancer Therapy; mCOH= Modified City of
Hope Quality of Life-Ostomy
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could be the perception (or re-conceptualization) of QoL
after CRC diagnosis [44]. Nevertheless other studies
reported no association between tumor stage and QoL
[11,30].
Surgical procedures can affect various aspects of QoL
due to physical and psychological consequences. Patients
undergoing surgical procedures experimented a rapid
QoL decline after surgery with a gradually restore about
3 month after [45]. Moreover, older patients are slower
to restore their QoL [46].
Lower QoL both in laparoscopic and open surgery was
found in older patient compared to the younger one [46],
but only short-term QoL differences were found between
open and laparoscopic surgery [47]. A possible reason may
be the different occurrence of complications between the
two surgical techniques [48]. Furthermore, baseline QOL
was an important predictor of postoperative overall QOL
and all QOL subdomains with a higher risk for difficult
postoperative courses and auxiliary services associated
with poor baseline QoL [49].
An important consequence of colorectal surgery is
stoma. The presence of stoma influenced negatively the
QOL if compared with patients undergoing a sphincter-
saving resection [50], but not all authors found a signifi-
cant difference [9,51]. The most important aspect influ-
enced by the presence of stoma was the social component
of QoL as assessed by a recent systematic review con-
ducted on 10 studies [52].
The physical and psychological disorders resulting from
stoma vary by gender. In female patients, a worse psycholo-
gical [28] and physical [32] QoL score was reported. On the
contrary, a reduction in mental health [28] and sexual func-
tioning [53] was found in man. These and other problems
related to stoma, such as worse fatigue, dyspnea, loss of
appetite and changing in body image perception, gradually
reduce a person’s confidence and his social relations [54].
However, the impact of stoma could be influenced nega-
tively by low income and problems in paying for stoma sup-
plies [55], and positively by receiving therapy support with
stoma-education programs and counseling [56,57].
Symptoms induced by cancer or its treatment are also
very important. Many prospective studies investigated
the role of bowel symptoms such as diarrhea, fecal con-
trol and constipation [58,59], but also fatigue and loss of
appetite are very common and affected significantly QoL
in CRC [36].
Other factors
Some lifestyle factors such as physical activities, diet,
alcohol intake and smoke were associated to QoL. A
moderate or intense physical activity is correlated to a
higher physical QoL due to lower levels of fatigue and
distress [60]. A quality diet (rich in fruit and vegetables,
and low in fat) and the administration of probiotics
reduced bowel dysfunction, which can markedly
decrease QoL [61-64]. Smoking was associated with a
lower QoL [65], and controversy to alcohol intake [30].
Multiple behaviors changes have a better cumulative
effect on QoL than single lifestyle modifications [63,66].
Intervention to improve QoL in CRC
In order to improve QoL in CRC patients it is important
to, first identify the patient with a higher risk to have a
low QoL and then intervene to the modifiable factors.
Fixed factors such as age or sex have only a marginal
role in QoL and others are potentially modifiable.
Therefore, a wide range of interventions have been
developed to improve QoL in CRC survivors. We can
improve QoL by reducing psychological morbidity and
facilitating crisis adaptation with educational programs,
self-help groups, psychosocial interventions, cognitive
behavioral therapy, coping, and certainly drugs. For
example, a randomized trial on 200 with cancer found
an improvement in depression and anxiety by physical
exercise, intervention group therapy and antidepressants
[67]. A moderate physical activities should be suggested,
when possible, to reduce some symptoms such as fati-
gue, pain and insomnia [64]. Bowel symptoms could be
reduced with modification of diet and the use of probio-
tics [62-64].
Psychosocial interventions can be classified in educa-
tional programs and psychotherapeutic interventions.
Educational problems improve the cancer-related knowl-
edge, its treatment and the emotional reactions to it.
Psychotherapeutic interventions, individual or in groups,
covers a wide range of approaches including assistance
in expressing emotions, increasing patients’ sense of
coherence, enhancing personal resources, improving
communication, gaining control and improving coping
skills. These interventions help to decrease somatic
symptoms and psychosocial sequelae of CRC and its
treatment, and improving QoL as showed on a prospec-
tive study [68].
This is also true for surgery consequences. Specific
training, like anal training after rectal resections by
reducing stool frequency, improves both general and
specific QoL [69]. A cross-sectional study and a recent
systematic review found that education of patient living
with stoma helped to deal with sexual difficulties, diet-
ary and physical activity restriction and in general with
their lifestyle [57,70]. Furthermore, in a prospective
longitudinal study was showed that groups’ activities by
sharing personal experiences helps to reduce the isola-
tion and the feelings of loneliness leading by stoma [71].
Relationship to survival
QoL is also known to be an independent predictor of
survival and response to therapy in cancer patients
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[72,73]. Broun et al. found that a 10-point increase in
baseline global QoL scores (using EORTC QLQ-C30)
was associated with a 7% decreased risk of death [74].
This result was also showed for other types of cancer
[75,76]. Some authors proposed a theory according to
which QoL could have a direct influence on tumor
behavior and survival [77,78], others suggested that QoL
had a direct influence on therapy adherence and conse-
quently on survival [79]. Moreover, a recent 18-month
trial suggested that baseline QoL influenced CRC
patient’s survival [49].
Discussion and conclusion
Various determinants of QoL in CRC had been investi-
gated and the results mainly shown that physical pro-
blems linked to symptoms and surgical procedures, such
as bowel problems and stoma are the most common.
On the socio-demographic characteristics, only the
socioeconomic status seems to have a well determined
role, probably due to the better access to medical care.
The presence of a higher comorbidity number was the
most important health-related factor, but it must be
considered that some of them could be a consequence
of CRC. Moreover, a significant higher prevalence of
distress, depression and anxiety were reported in CRC
patients than the general population.
Findings on CRC stage by determining symptoms,
treatment procedure and consequently overall survival
showed the importance of disease stage on QoL. Its role
is essential both for the clinical aspect and the psycholo-
gical consequences that affect QoL after diagnosis [43].
When comparing the effect of different surgical proce-
dures on QoL, only short-term benefits were found for
laparoscopy. This could be explained by less post-opera-
tive complications with laparoscopic procedure [2,46].
Similarly, higher QoL score for the younger patient was
linked to the number and the severity of postoperative
and late complications occurred after both open and
laparoscopic surgery [46,48].
The importance of symptoms has been reported in
many studies since they affect directly and indirectly
QoL in CRC survival. In fact the presence of diarrhea,
incontinence, fatigue and pain in addition to having
direct effects on QoL influenced the daily activities and
hobbies, and interfere with family and social life [36,59].
Despite specific physical and psychological problems,
the overall QoL in CRC patient is good both in short
[80] and long-term survivors [11,27]. Several theories
can be called upon to explain these findings.
One could be the process of internal recalibration and
the shift in personal values to new understanding,
known as reframing/response shift. This changes the
patient’s internal standards leading to a different estima-
tion of their QoL [81].
Other two constructs of positive consequences after
cancer diagnosis/treatment describe the change following
a so stressful experience, benefit finding (BF) and post-
traumatic growth (PTG). These two concepts are slightly
different, but sometimes have been used interchangeably
[82]. BF is defined as an individual process in which the
patient perceives that major positive changes have
occurred as a result of challenging life events. In contrast,
PTG refers to benefits associated with changes in appre-
ciation of life, interpersonal relationship, and self-percep-
tion often manifested through personal strength, spiritual
change and globally as life perspective. Moreover, these
two concepts are temporally different. BF start immedi-
ately after diagnosis, instead PTG can be developed even
years after the cancer diagnosis [83].
The limitations of a literature review of this nature are
the lack of systematic research of articles and lack of a
gold standard for measuring QoL. Very heterogeneous
instruments and different statistical analyses were used,
making difficult a comparison across studies. However,
all studies used well-validated instruments. Other short-
comings of the exanimated studies which may introduce
a bias when comparing QoL results are: data acquisition,
low response rates, non-random drop-out, small sample
size and the different correction for confounding factors.
Furthermore role of chemotherapy and radiotherapy
treatment was not investigated.
Despite some limitations, this review is useful for a
better understanding of QoL and its determinants in
CRC patients. Due to the burden of this disease and the
higher survival rate, both for early diagnosis and new
treatment, the QoL in survivors of CRC should be a
priority for public health research. The knowledge about
the determinants of QoL could help to identify survivors
with special needs. Moreover these findings may be use-
ful for cancer clinicians in taking therapy and surveil-
lance-related decisions in order to enhance the QoL of
people with CRC.
Finally, although patients have a good QoL compared
with the general populations, a significant number of
determinants are potentially modifiable variable. Future
intervention studies are needed to improve certain
aspects of quality of care to determine whether those
changes lead to increased QoL. Moreover, research
should be directed to large-scale prospective studies
using well validated QoL instruments to facilitate the
comparison of results.
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